The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing Sarcoma

Magnetic resonance imaging (MRI) is the modality of choice for local staging and response evaluation of Ewing sarcoma (EwS). Aim of this study was to determine the relevance of tumor volume response (TVR) in relation to histological response (HisRes) and survival, in order to evaluate if early modification of chemotherapy might be indicated in patients with inadequate TVR.

[1]  A. Degnan,et al.  Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors. , 2018, Clinical imaging.

[2]  A. Moreau,et al.  Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma , 2017, PloS one.

[3]  U. Dirksen,et al.  Management and Outcome of Ewing Sarcoma of the Head and Neck , 2016, Pediatric blood & cancer.

[4]  H. Daldrup-Link,et al.  Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome. , 2016, Radiology.

[5]  K. Hess,et al.  Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. , 2015, International journal of radiation oncology, biology, physics.

[6]  H. Lederman,et al.  Magnetic Resonance Imaging in Pediatric Bone Tumors , 2014, Current Radiology Reports.

[7]  U. Dirksen,et al.  Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  K. McHugh,et al.  Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments? , 2013, Radiology.

[9]  Lihua Chen,et al.  The Correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis , 2013, PloS one.

[10]  U. Dirksen,et al.  Ewing Sarcoma: Biology-Based Therapeutic Perspectives , 2012, Pediatric hematology and oncology.

[11]  L. Schwartz,et al.  Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  U. Dirksen,et al.  Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  James R. Anderson,et al.  Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Craft,et al.  Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO‐E.W.I.N.G. 99 clinical trial , 2006, Pediatric blood & cancer.

[15]  H. Brisse,et al.  Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment , 2004, Pediatric Radiology.

[16]  J. Bloem,et al.  Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging , 1994, Skeletal Radiology.

[17]  G. Delling,et al.  Morphological grades of regression in osteosarcoma after polychemotherapy — Study COSS 80 , 2004, Journal of Cancer Research and Clinical Oncology.

[18]  B. Bui,et al.  Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study) , 2001, British Journal of Cancer.

[19]  W. Reddick,et al.  Tumor volume or dynamic contrast-enhanced MRI for prediction of clinical outcome of Ewing sarcoma family of tumors , 2001, Pediatric Radiology.

[20]  A. Craft,et al.  Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Dalinka,et al.  Magnetic resonance imaging in primary bone tumors. , 2000, Seminars in roentgenology.

[22]  E. Gehan,et al.  Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)? , 2000, Journal of the National Cancer Institute.

[23]  D. Vanel,et al.  Imaging Evaluation of the Response of High-Grade Osteosarcoma and Ewing Sarcoma to Chemotherapy with Emphasis on Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2000, Seminars in musculoskeletal radiology.

[24]  P. Pynsent,et al.  Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma , 1999 .

[25]  J. Bloem,et al.  Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing’s sarcoma: review of current imaging modalities , 1998, Skeletal Radiology.

[26]  S. Ferrari,et al.  Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  C. R. Pinkerton,et al.  Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation. , 1992, Radiology.

[28]  R. Souhami,et al.  MRI in primary bone tumors: therapeutic implications. , 1991, European Journal of Radiology.

[29]  W. Meyer,et al.  Use of MR imaging to assess results of chemotherapy for Ewing sarcoma. , 1990, AJR. American journal of roentgenology.

[30]  J. Bloem,et al.  Radiologic staging of primary bone sarcoma: MR imaging, scintigraphy, angiography, and CT correlated with pathologic examination. , 1988, Radiology.

[31]  J. Michaelis,et al.  Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.